ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1595

Electroclinical Correlates and Outcome Of Status Epilepticus In Systemic Lupus Erythematosus

Jamal Mikdashi1, Tricia Ting2 and Allan Krumholz3, 1Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, 2Neurology, University of Maryland. School of Medicine, Baltimore, MD, 3Neurology, University fo Maryland school of Medicine, Baltimore, MD

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects II: Central Nervous System Manifestations, Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Predictors of seizures and epilepsy in systemic lupus erythematosus (SLE) patients are well described but descriptions of status epilepticus (SE) have thus far been limited to isolated case reports. The purpose of this study is to determine the electro-clinical characteristics as potential predictors of long-term outcome of SE in SLE. 

Methods: This is an observational study of consecutive SLE patients with SE, enrolled out of the Maryland Lupus cohort that consists of 1138 SLE patients. Demographic, clinical features, laboratory data, brain magnetic resonance imaging (MRI) studies and video electroencephalography (EEG) were examined during SE event. Outcome was determined at 12 months following SE event. Seizure not related to SLE were excluded.

Results:

In this SLE population, 78 (6.9%) of all patients had seizures related to SLE, and of these 7 (9.0%) had SE.  At the SE events, patients [mean age 21.4 years, 72 % women, 72 % African American, and a mean duration of SLE of 6.5 years] presented with cutaneous vasculitis (57%), arthritis (43 %), psychosis ( 29 %), nephritis (14 %) and ischemic stroke (14 %). Convulsive SE was observed in 6 patients (3 generalized, 3 complex partial with secondary generalized) and non-convulsive SE in 1. Prolonged electrographic seizure activity (1-3 days) with continuous slowing and multifocal spikes in the bifornatal and temporal regions, associated with refractory complex partial and generalized seizures were observed in 5 patients. EEG seizures resolved abruptly in 2 patients. In addition to immunotherapy, multiple anti-epileptic drugs were needed to control SE in all patients.

All SE patients had a symptomatic structural lesion with probable etiologic significance with increased T2/FLAIR hyperintensity in the front- temporal and posterior cortex, and hypointense lesions in the regions of the amygdyla –hippocampal complex, thalamus and basal ganglia areas. Restricted weighted sequence images demonstrated restricted diffusion in the corresponding cortical regions of the frontal and temporal lobes in two patients. Two patients had normal initial brain MRI, but abnormal lesions were identified using functional FDG-PET scanning.

A favorable clinical and EEG response was recognized in all SLE patients with SE, with improvement in consciousness and survival. Recurrent seizure events were observed in 3 patients following the SE event, while recurrent SE events were observed in one patient who developed mesial temporal sclerosis overtime. Poor functional and cognitive outcome observed in 3 (43 %) patients, was associated with prolonged SE event, presence of cortical and subcortical structural lesions on brain MRI that correlated with the recorded EEG abnormality. No mortality among the SE patients was observed. 

Conclusion: Overall, SLE patients with SE seem to have a favorable clinical outcome. Patients with prolonged SE events with a greater cortical-subcortical lesion burden on brain MRI have poor physical and cognitive function on long-term outcome. Identifying the pathogenic role of specific SLE related autoantibodies/cytokines in relation to brain structural lesions of SLE patients with SE is needed.


Disclosure:

J. Mikdashi,
None;

T. Ting,
None;

A. Krumholz,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/electroclinical-correlates-and-outcome-of-status-epilepticus-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology